Pure Global

Sickle Cell Rapid Test - India CDSCO Medical Device Registration

Sickle Cell Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000082_578a3211bbb7984d85c0620e03405a7e_966a05ee238ff504a42d7835affd74aa. This device is marketed under the brand name BIOGENIX. The license holder is Biogenix Inc. Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Uttar Pradesh.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Sickle Cell Rapid Test
UID: MFG/IVD/2020/000082_578a3211bbb7984d85c0620e03405a7e_966a05ee238ff504a42d7835affd74aa

Brand Name

BIOGENIX

Device Class

Class B

Approving Authority

Uttar Pradesh

Product Information

The Sickle cell test is a lateral flow chromatographic qualitative immunoassay to aid in the rapid diagnosis of sickle cell disorders of hemoglobins A, S, and C using fingerstick or venipuncture whole blood samples

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing